From dramatic weight loss transformations to cautionary tales, celebrities are opening up about their experiences with Ozempic and Mounjaro. Discover their honest opinions and the health risks they faced!
In a surprising move, Lars Fruergaard Jørgensen is stepping down as CEO of Novo Nordisk after years of leading the company through a successful phase in obesity and diabetes medications. As the search for his successor begins, what does this mean for the future of the pharmaceutical giant?
